Latest Strategy News

OzAurum Resources has delivered another round of strong near-surface gold intercepts at its Mulgabbie North Paleochannel Project, reinforcing a low-cost heap leach development pathway and progressing site construction.

Vitasora Health Limited has secured $4 million in a strongly oversubscribed placement, anchored by a $3 million cornerstone investment from private investor Bob Peters. The capital boost supports rapid growth in monthly billings and funds the company through expected cashflow breakeven in the second half of 2026.

Brazilian Rare Earths (ASX: BRE) has identified a sprawling rare earth corridor extending over 9 km south of its Monte Alto Deposit, with surface samples hitting up to 39.6% TREO and drilling confirming high-grade mineralisation from surface to bedrock.

Legacy Minerals has kicked off an 8-hole, 4,000m diamond drilling program at its Emu Copper-Gold Prospect, marking the first modern exploration of this historically significant target within the Mt Carrington Project in northern NSW.

Megaport Limited is raising approximately A$827 million through a fully underwritten entitlement offer to finance four major AI contracts and build an on-demand GPU Pool, aiming to establish a globally-distributed AI inference cloud.

Barton Gold has completed a 3,677m drilling program at its Tolmer Silver discovery, confirming high-grade silver mineralisation with assays exceeding 2,000 gram-metres and producing a concentrate grading over 100,000 g/t Ag without complex processing.

FMR Resources has raised $5 million through a two-tranche placement aimed at accelerating exploration at its La Lorena and Llahuin copper projects in Chile, with participation from major shareholders and new investors.

Axel REE has appointed Dr Patience Mpofu as Managing Director, positioning the company to advance its rare earths portfolio from exploration into commercial development with planned in-situ recovery trials.

Imricor Medical Systems has submitted the third of four Premarket Approval modules to the FDA, marking a key step towards US approval of its MR-guided cardiac ablation devices.

Alfabs Australia is sharpening its financial focus with a plan to double or triple free cash flow by FY2028, underpinned by a disciplined capital framework and a clear dividend reinstatement path.

Orpheus Uranium has secured a binding agreement to acquire seven exploration licences from Adavale Resources, significantly expanding its Marree Project landholding in South Australia’s Northern Flinders Ranges and advancing the project to advanced exploration status.

LTR Pharma has locked in Strive Specialties as its exclusive US pharmacy fulfilment partner for ROXUS, marking a critical step towards commercial launch in the US erectile dysfunction market.